Revealed hours earlier by Brazilian authorities, Professor David Hui said CoronaVac’s final-stage testing results were ‘quite desirable’ Comparing its efficacy rates against higher numbers for Pfizer-BioNTech and AstraZeneca-Oxford versions could lead to false conclusions, he added


Similar articles:

Leave a Reply

Your email address will not be published. Required fields are marked *